Addison’s Disease in Dogs: Symptoms, Diagnosis, Treatment, and Management Guide
This article is reviewed for clinical accuracy. Always consult your veterinarian for diagnosis and treatment.
Key Takeaways
- Addison’s disease (hypoadrenocorticism) is caused by insufficient production of glucocorticoids (cortisol) and mineralocorticoids (aldosterone) from the adrenal cortex; in the most common form (primary hypoadrenocorticism), the adrenal cortex is destroyed by immune-mediated attack; aldosterone deficiency causes the characteristic electrolyte abnormalities: hyponatremia (low sodium) and hyperkalemia (high potassium), because aldosterone normally drives sodium retention and potassium excretion at the renal collecting duct; when aldosterone is absent, sodium is wasted in urine, potassium accumulates, and the resulting sodium:potassium (Na:K) ratio falls below 27 (normal is 27 to 40).
- Addison’s disease is called the “Great Pretender” of veterinary medicine because its clinical signs are vague, waxing and waning, and mimic many other conditions: episodic weakness, vomiting, diarrhea, weight loss, and poor appetite are the most common presenting complaints; many dogs are worked up multiple times for gastrointestinal disease, neurological problems, or other diagnoses before Addison’s is recognized; the disease is most common in young to middle-aged female dogs of predisposed breeds (Standard Poodle, Bearded Collie, Portuguese Water Dog, Great Dane, Soft Coated Wheaten Terrier), but occurs in any breed, any age, and either sex.
- Atypical Addison’s disease refers to a subset (approximately 30 to 40 percent of cases) in which only cortisol deficiency is present without aldosterone deficiency; the electrolytes are normal (normal Na:K ratio greater than 27), eliminating the classic diagnostic pointer; atypical Addison’s is caused by selective destruction of the zona fasciculata (cortisol-producing zone) with sparing of the zona glomerulosa (aldosterone-producing zone), or by secondary hypoadrenocorticism (pituitary failure to produce ACTH, which leaves the aldosterone pathway relatively intact); atypical dogs present with the glucocorticoid-deficiency signs (weakness, vomiting, hypoglycemia, weight loss) but not the electrolyte abnormalities, making the diagnosis even more challenging.
- The ACTH stimulation test is the gold standard for diagnosing both typical and atypical Addison’s disease: a baseline cortisol sample is drawn, synthetic ACTH (cosyntropin, Cortrosyn) is administered at 5 mcg/kg IV (low-dose protocol) or 250 mcg total IV (standard protocol), and a post-stimulation cortisol is measured 60 minutes later; in Addison’s disease, both the baseline and post-stimulation cortisol are typically less than 2 mcg/dL (the adrenal cortex cannot respond to ACTH stimulation because it has been destroyed); a post-stimulation cortisol above 2 mcg/dL essentially rules out hypoadrenocorticism; a single baseline cortisol less than 2 mcg/dL is a reasonable screening test with high sensitivity, but confirmatory ACTH stimulation testing is the standard of care.
- Acute Addisonian crisis is a life-threatening emergency in which severe aldosterone and cortisol deficiency produce cardiovascular collapse: the hyperkalemia from aldosterone deficiency causes bradycardia, atrial standstill (loss of P waves on ECG), and eventually ventricular fibrillation or asystole at potassium concentrations above approximately 8 to 9 mEq/L; the hyponatremia, combined with volume depletion from renal sodium loss and vomiting/diarrhea, causes hypovolemic shock; crisis treatment requires aggressive IV 0.9% sodium chloride (normal saline) administration to replace sodium and volume, dexamethasone sodium phosphate (which does not cross-react with the cortisol assay, allowing ACTH stimulation testing during crisis), and careful management of hyperkalemia; desoxycorticosterone pivalate (DOCP, Percorten-V) or fludrocortisone can be given after diagnosis is confirmed.
- Long-term management of Addison’s disease requires lifelong hormone replacement: mineralocorticoid replacement with either monthly intramuscular DOCP (desoxycorticosterone pivalate, Percorten-V, starting at 2.2 mg/kg IM every 25 to 28 days, dose adjusted based on electrolytes) or daily oral fludrocortisone (Florinef, 0.01 to 0.02 mg/kg/day, which has both mineralocorticoid and some glucocorticoid activity); glucocorticoid supplementation with prednisone (0.1 to 0.2 mg/kg/day) for dogs on DOCP, or relying on the glucocorticoid activity of fludrocortisone in dogs on Florinef; during periods of physiological stress (illness, surgery, trauma, travel, boarding), glucocorticoid doses must be doubled or tripled (“stress dosing”) because the adrenal glands cannot mount the normal cortisol stress response; owners must understand this principle and carry injectable dexamethasone or hydrocortisone for emergencies.
The 4-year-old Standard Poodle had been brought to the clinic three times in the past 8 months. The first two visits had been for vomiting and lethargy that resolved on their own within a day or two after IV fluids; bloodwork was run both times and the results were mildly abnormal but non-specific. This time, the dog had collapsed in the backyard after a short walk. On arrival she was bradycardic (heart rate 42 beats per minute), profoundly weak, and could not stand without support. The ECG showed absent P waves. The serum potassium came back at 8.4 mEq/L. The sodium was 128 mEq/L. The Na:K ratio was 15. The attending veterinarian recognized the picture immediately: atrial standstill from severe hyperkalemia, classic for Addisonian crisis. The dog that had been dismissed twice before with “stress gastritis” had Addison’s disease. Aggressive IV saline and dexamethasone were started. By morning she was sitting up and asking for food. The diagnosis was confirmed with an ACTH stimulation test showing a baseline cortisol of 0.6 mcg/dL and a post-stimulation cortisol of 0.8 mcg/dL. She would need lifelong hormone supplementation, but with that, she would live a completely normal life.
Adrenal Cortex Anatomy and Hormone Deficiencies
The adrenal glands sit just cranial to each kidney and consist of two distinct layers: the outer cortex (which produces steroid hormones) and the inner medulla (which produces catecholamines like epinephrine and norepinephrine). The cortex has three functional zones, each producing distinct hormones:
- Zona glomerulosa (outermost zone): produces aldosterone (the primary mineralocorticoid); aldosterone acts on the principal cells of the renal collecting duct via mineralocorticoid receptors, stimulating sodium (Na+) reabsorption and potassium (K+) and hydrogen ion (H+) excretion; aldosterone secretion is regulated primarily by the renin-angiotensin-aldosterone system (RAAS) in response to decreased renal perfusion pressure, and is largely independent of ACTH; this is why secondary hypoadrenocorticism (ACTH deficiency from pituitary disease) typically does not cause electrolyte abnormalities: the zona glomerulosa remains responsive to RAAS signals even when ACTH is absent
- Zona fasciculata (middle zone): produces cortisol (the primary glucocorticoid); cortisol has widespread effects including blood glucose maintenance (via gluconeogenesis), immune modulation, cardiovascular support (maintaining vascular tone and response to catecholamines), and the physiological stress response; cortisol production is tightly regulated by the hypothalamic-pituitary-adrenal (HPA) axis: the hypothalamus releases CRH (corticotropin-releasing hormone), which stimulates the pituitary to release ACTH, which drives zona fasciculata cortisol production; without ACTH, the zona fasciculata atrophies and cortisol production fails
- Zona reticularis (innermost cortical zone): produces adrenal androgens (dehydroepiandrosterone, androstenedione); these are not clinically significant in Addison’s disease in dogs
In primary hypoadrenocorticism (the most common form), immune-mediated destruction of the adrenal cortex affects all three zones, eliminating both aldosterone and cortisol production. In secondary hypoadrenocorticism, the pituitary fails to produce ACTH (from a pituitary tumor, infarct, or iatrogenic steroid suppression), the zona fasciculata atrophies from lack of ACTH stimulation, and cortisol production fails; the zona glomerulosa is relatively spared because it does not depend primarily on ACTH, so electrolytes remain normal.
Causes of Hypoadrenocorticism
| Type | Cause | Electrolytes | Notes |
|---|---|---|---|
| Primary hypoadrenocorticism (typical) | Immune-mediated adrenocortical destruction (most common); less commonly: granulomatous disease, hemorrhage, infarction, neoplastic destruction, fungal infection (Histoplasma, Blastomyces) | Hyponatremia + hyperkalemia; Na:K ratio below 27 | Both aldosterone and cortisol deficient; 70% of primary cases |
| Primary hypoadrenocorticism (atypical) | Selective glucocorticoid deficiency; early immune-mediated disease affecting only the zona fasciculata; may progress to typical form over time | Normal Na:K ratio (greater than 27) | Cortisol deficient only; no electrolyte changes; 30% of primary cases; may be diagnosed on ACTH stimulation after workup for GI or neurological signs |
| Secondary hypoadrenocorticism | Pituitary failure to produce ACTH: pituitary tumor, infarction, cranial trauma; most commonly iatrogenic from abrupt withdrawal of long-term corticosteroid therapy (suppresses HPA axis) | Normal Na:K ratio (zona glomerulosa preserved) | Only cortisol deficient; electrolytes normal; iatrogenic form most common cause of secondary hypoadrenocorticism; steroid withdrawal must be gradual after long-term use |
Clinical Signs: The Great Pretender
Chronic/Episodic Signs (Most Common Presentation)
Most dogs with Addison’s disease present with a history of chronic, episodic, waxing and waning clinical signs that improve and relapse, often appearing to respond partially to symptomatic treatment (IV fluids, antiemetics) and then recurring weeks to months later. This relapsing pattern is characteristic and should heighten suspicion. The most common signs include:
- Lethargy and exercise intolerance, often described as the dog “not being herself” or seeming unusually tired after normal activity
- Anorexia or reduced appetite (from both cortisol deficiency and electrolyte abnormalities affecting GI motility)
- Vomiting, with or without obvious triggering cause; often described as episodic
- Diarrhea, which may be intermittent; can contain fresh blood (hematochezia) from gastrointestinal ulceration related to cortisol deficiency
- Weight loss over weeks to months
- Shaking or trembling episodes (from hypoglycemia in some cases, or from generalized weakness)
- Polyuria and polydipsia (increased water intake and urination; related to sodium loss and inability to concentrate urine without adequate cortisol)
- Abdominal pain on palpation in some cases, often attributed to GI disease
Acute Addisonian Crisis
An Addisonian crisis (also called acute adrenal insufficiency) is the sudden decompensation of an Addisonian dog, typically triggered by a stressful event (illness, infection, surgery, boarding, travel, trauma) that demands a cortisol stress response the adrenal glands cannot provide. The clinical picture is dramatic: collapse and profound weakness, inability to stand, severe dehydration, bradycardia (heart rate below 60 beats per minute in a dog that is hypotensive and collapsed, which is the opposite of the tachycardia expected with shock), pale or gray mucous membranes, prolonged capillary refill time, weak thready pulse, hypothermia, and vomiting or diarrhea. The bradycardia in the context of shock is a critical diagnostic clue: a collapsed, dehydrated dog should be tachycardic from compensatory sympathetic activation; bradycardia in this context strongly suggests hyperkalemia-induced cardiac conduction abnormality (atrial standstill) and should immediately prompt an electrolyte measurement. ECG findings in hyperkalemic crisis: absent or flattened P waves (atrial standstill), peaked T waves, widened QRS complexes, bradycardia; at extreme potassium levels (above 8 to 9 mEq/L), ventricular fibrillation or cardiac arrest can occur.
Diagnosis
Routine Bloodwork Abnormalities Suggesting Addison’s
| Test | Finding in Addison’s Disease |
|---|---|
| Serum sodium (Na) | Hyponatremia: typically 120 to 135 mEq/L (normal 145 to 155 mEq/L); from aldosterone deficiency causing renal sodium wasting |
| Serum potassium (K) | Hyperkalemia: typically 5.5 to 9.0+ mEq/L (normal 3.5 to 5.0 mEq/L); from aldosterone deficiency causing renal potassium retention |
| Sodium:Potassium ratio (Na:K) | Below 27 (normal 27 to 40); a Na:K ratio below 27 is the classic screening indicator; below 24 is strongly suggestive; present in approximately 70% of primary Addison’s cases (not in atypical or secondary forms) |
| BUN and creatinine | Elevated from pre-renal azotemia (dehydration and hypovolemia); may be severe in crisis; improves rapidly with IV saline |
| Blood glucose | Normal to low; hypoglycemia occurs in some Addisonian dogs from cortisol deficiency impairing gluconeogenesis; hypoglycemia is more common in secondary hypoadrenocorticism |
| Total CO2 / bicarbonate | Mild to moderate metabolic acidosis from aldosterone deficiency (impaired H+ excretion) and lactic acidosis from poor perfusion |
| CBC | Reverse stress leukogram: lymphocytosis and eosinophilia in a dog that is clearly ill; a normal dog under physiological stress shows lymphopenia and eosinopenia from cortisol; the absence of this expected response (normal or elevated lymphocytes and eosinophils) in a sick dog is a classic Addison’s clue |
| Serum albumin | Low normal to mildly low; protein-losing enteropathy from GI involvement; chronic weight loss |
| Urinalysis | Poorly concentrated urine (specific gravity close to 1.010 to 1.020 in a dehydrated dog); reflects the inability to concentrate urine due to medullary washout from chronic sodium loss and lack of cortisol effect on free water clearance |
ACTH Stimulation Test: Gold Standard
The ACTH stimulation test remains the definitive diagnostic test for hypoadrenocorticism. Protocol: collect baseline cortisol sample (pre-ACTH); administer synthetic ACTH (cosyntropin/Cortrosyn) at 5 mcg/kg IV (low-dose protocol, preferred by many internists to reduce cost) or 250 mcg total IV regardless of body weight (standard protocol); collect post-stimulation cortisol 60 minutes after injection. Interpretation: post-stimulation cortisol below 2 mcg/dL confirms hypoadrenocorticism; post-stimulation cortisol above 2 mcg/dL essentially rules out Addison’s disease. Both baseline and post-stimulation cortisol are below 2 mcg/dL in most Addisonian dogs because the adrenal cortex has no functional reserve to respond to ACTH stimulation. A baseline cortisol below 2 mcg/dL has approximately 98 percent sensitivity for Addison’s and can be used as a rapid screening test to stratify which patients need full ACTH stimulation testing. Dexamethasone sodium phosphate does not cross-react with the cortisol immunoassay and can be administered for crisis stabilization before the ACTH stimulation test without invalidating the test result; prednisone and prednisolone do cross-react and must be avoided before testing.
Acute Crisis Treatment Protocol
Addisonian crisis is a medical emergency. Treatment priorities are: restore intravascular volume, correct hyperkalemia-induced cardiac arrhythmia, replace glucocorticoids, and diagnose the underlying condition. The standard acute treatment protocol:
- IV access and fluid resuscitation: 0.9% sodium chloride (normal saline, NOT lactated Ringer’s which contains potassium) at a shock dose (90 mL/kg/hour in dogs, titrated to response); normal saline simultaneously replaces sodium, expands volume, and dilutes potassium; it is the single most important intervention in Addisonian crisis and must be started immediately
- Glucocorticoid replacement: dexamethasone sodium phosphate 0.5 to 2 mg/kg IV; dexamethasone provides immediate glucocorticoid activity without interfering with the cortisol immunoassay; if the ACTH stimulation test has already been performed or is not feasible, hydrocortisone sodium succinate (Solu-Cortef) 0.5 to 1 mg/kg IV can be used and continued as a constant rate infusion
- ECG monitoring: continuous cardiac monitoring for hyperkalemia-induced bradycardia and atrial standstill; potassium above 8 mEq/L with cardiac arrhythmia may require specific interventions before potassium normalizes from fluid therapy alone: calcium gluconate 10% at 0.5 to 1 mL/kg IV slowly over 10 to 15 minutes (cardioprotective, does not lower potassium but stabilizes cardiac membrane); regular insulin (0.1 units/kg IV) with dextrose supplementation (drives potassium intracellularly); sodium bicarbonate (1 mEq/kg IV) if severe metabolic acidosis is present
- ACTH stimulation test: draw baseline cortisol before or immediately after administering dexamethasone, administer ACTH, draw 60-minute post-stimulation sample; can be performed in the middle of crisis stabilization without interrupting treatment (as long as dexamethasone, not prednisone, is used)
- Mineralocorticoid replacement: once the dog is stable and the diagnosis is confirmed, DOCP (desoxycorticosterone pivalate, Percorten-V) 2.2 mg/kg IM can be given; the first DOCP injection provides 25 to 28 days of mineralocorticoid coverage and electrolytes typically normalize within 24 to 48 hours of the first injection and IV saline
Long-Term Management
Mineralocorticoid Replacement Options
Dogs diagnosed with primary hypoadrenocorticism (typical form with electrolyte abnormalities) require lifelong mineralocorticoid replacement. Two options are available:
- Desoxycorticosterone pivalate (DOCP, Percorten-V): injectable depot formulation given IM every 25 to 28 days; initial dose 2.2 mg/kg IM; electrolytes (Na and K) are rechecked 12 to 14 days after each injection (the trough period) and the dose or interval is adjusted to maintain normal electrolytes at the trough; most dogs are maintained between 1.5 and 2.2 mg/kg every 25 to 28 days; DOCP has minimal glucocorticoid activity so prednisone supplementation is always required; the injectable format is convenient for owners who have difficulty administering daily pills
- Fludrocortisone (Florinef): daily oral tablet with both mineralocorticoid and weak glucocorticoid activity; initial dose 0.01 to 0.02 mg/kg/day; dose is adjusted based on electrolyte monitoring every 1 to 2 weeks initially, then every 3 to 6 months once stable; most dogs require dose increases over the first 6 to 18 months; some dogs on fludrocortisone do not require additional prednisone supplementation due to the drug’s glucocorticoid activity, though this should be assessed individually; fludrocortisone is typically less expensive than DOCP but requires daily owner administration
Glucocorticoid Supplementation and Stress Dosing
Dogs on DOCP require concurrent daily prednisone (0.1 to 0.2 mg/kg/day orally). All Addisonian dogs, regardless of their mineralocorticoid therapy, require “stress dosing” of glucocorticoids: during any physiological stress (illness, fever, vomiting, surgery, trauma, boarding, significant travel, or any situation the dog finds distressing), the daily prednisone dose should be doubled or tripled for the duration of the stressful event and for 24 to 48 hours afterward. This is because the normal adrenal stress response (cortisol surge) cannot occur in Addisonian dogs, and without supplemental glucocorticoids during stress, the dog can deteriorate rapidly into crisis. Every owner of an Addisonian dog must understand this principle, have a supply of prednisone at home, and have a protocol for when to seek emergency care (persistent vomiting despite oral prednisone increase, collapse, extreme lethargy).
US Cost Overview for Addison’s Disease
| Service | Typical US Cost |
|---|---|
| Initial exam and basic bloodwork (CBC, chemistry, electrolytes) | $200 to $450 |
| ACTH stimulation test (cosyntropin + two cortisol assays) | $150 to $350 |
| Emergency crisis stabilization (IV fluids, dexamethasone, monitoring) | $800 to $2,500 |
| First DOCP injection (Percorten-V) + electrolyte recheck | $100 to $250 per injection |
| DOCP ongoing (monthly injection at veterinary clinic) | $80 to $200 per month depending on dog size |
| Fludrocortisone (Florinef) daily oral tablet | $30 to $80 per month (dose-dependent) |
| Prednisone (daily oral supplement) | $10 to $20 per month |
| Electrolyte monitoring bloodwork (every 3 to 6 months, stable patient) | $80 to $150 per visit |
| Annual comprehensive bloodwork and exam | $200 to $400 |
| Total estimated annual ongoing cost (stable, DOCP-managed, medium dog) | $1,500 to $3,500 |
Breed Predispositions
| Breed | Risk Notes |
|---|---|
| Standard Poodle | Most commonly overrepresented breed in case series; estimated prevalence 1.5 to 2% in the breed; often young females; familial inheritance suspected |
| Bearded Collie | Significantly elevated risk; immune-mediated disease cluster in the breed including hypoadrenocorticism, hypothyroidism, and immune-mediated hemolytic anemia |
| Portuguese Water Dog | Elevated risk; familial cases documented; genetic studies underway in the breed |
| Great Dane | Elevated risk in giant breeds; crisis presentation may be complicated by concurrent cardiac disease and size-related fluid management challenges |
| Soft Coated Wheaten Terrier | Elevated risk; also predisposed to protein-losing nephropathy and protein-losing enteropathy which can confound diagnosis |
| West Highland White Terrier | Elevated risk; also predisposed to multiple endocrine and immune-mediated conditions |
| Rottweiler | Moderate elevation; also predisposed to CrCL disease and cancer |
| Nova Scotia Duck Tolling Retriever | Immune-mediated disease cluster in the breed includes hypoadrenocorticism |
| Any breed, any age, either sex | Addison’s can occur in any dog; the “typical” patient (young adult female of predisposed breed) is common but not universal; male dogs and older dogs can be diagnosed |
Age-Specific Considerations
Young Dogs (Under 4 Years)
- Addison’s disease most commonly presents in young to middle-aged female dogs, with a median age at diagnosis of approximately 4 to 5 years; diagnosis in dogs under 2 years is uncommon but documented, particularly in Standard Poodles and Bearded Collies where familial/genetic factors are important; young dogs with episodic vomiting, lethargy, and poor appetite that improve with IV fluids but recur repeatedly should have electrolytes checked and Addison’s placed on the differential diagnosis even at a young age
- Young dogs diagnosed with Addison’s disease have excellent long-term prognoses with appropriate lifelong management; many Addisonian dogs live normal lifespans and have full quality of life; the most important initial steps after diagnosis are educating the owner thoroughly about stress dosing, emergency protocols, and monitoring for signs of under-replacement (returning weakness, vomiting) or over-replacement (polyuria/polydipsia, weight gain)
- Genetic counseling is relevant for young purebred Addisonian dogs of predisposed breeds; affected dogs should not be used for breeding, as familial inheritance is strongly suspected in Standard Poodles, Bearded Collies, and Portuguese Water Dogs; owners of littermates and related dogs should be counseled about the breed’s elevated risk and the symptoms to watch for
Adult Dogs (4 to 9 Years)
- The peak diagnostic window; most Addisonian dogs are diagnosed as young adults with a history of episodic illness; the diagnosis is often made after crisis presentation or after repeated workups for GI disease fail to identify a cause; the characteristic reverse stress leukogram (lymphocytosis and eosinophilia in a sick dog) on routine CBC is a consistent clue that should always prompt electrolyte measurement and ACTH stimulation testing
- Dogs diagnosed with atypical Addison’s (normal electrolytes, failed ACTH stimulation) should have electrolytes monitored every 6 to 12 months because a subset of atypical cases eventually develop aldosterone deficiency and transition to typical Addison’s over months to years; the transition may be preceded by borderline low Na:K ratios; catching this transition before crisis allows orderly initiation of mineralocorticoid therapy
- Iatrogenic secondary hypoadrenocorticism from abrupt steroid withdrawal is most commonly diagnosed in middle-aged dogs being treated for immune-mediated disease, allergies, or inflammatory conditions; any dog that has been on corticosteroids for more than 4 to 6 weeks should have the dose tapered gradually (over weeks to months depending on duration of therapy) rather than stopped abruptly to allow HPA axis recovery; dogs showing weakness, vomiting, or lethargy during or after steroid tapering should be evaluated for secondary hypoadrenocorticism
Senior Dogs (10 Years and Older)
- New-onset Addison’s disease in dogs over 10 years is less common than in young adults but does occur; senior dogs newly diagnosed with hypoadrenocorticism warrant additional workup for secondary causes (pituitary tumor, adrenal destruction from neoplasia or hemorrhage) that are more common in older animals; abdominal ultrasound to evaluate adrenal gland size (small, atrophied adrenals suggest immune-mediated primary disease; enlarged or asymmetric adrenals may suggest neoplastic destruction) and possibly brain MRI if a pituitary mass is suspected
- Senior Addisonian dogs already on long-term management may require dose adjustments as they age; body weight changes, concurrent diseases (renal insufficiency, cardiac disease), and altered drug metabolism can affect mineralocorticoid and glucocorticoid requirements; more frequent monitoring bloodwork (every 3 months rather than every 6 months) is appropriate for senior dogs on hormone replacement to catch early signs of over- or under-replacement
- Emergency crisis management in senior dogs requires awareness of concurrent diseases; aggressive IV saline appropriate for a young dog in Addisonian crisis may be too aggressive for a senior dog with pre-existing cardiac disease or renal insufficiency; senior dogs benefit from central venous pressure monitoring or echocardiographic assessment during aggressive fluid resuscitation, and cardiology consultation if concurrent cardiac disease is present
Myths and Facts About Addison’s Disease in Dogs
Normal electrolytes on bloodwork means my dog cannot have Addison’s disease.
Normal electrolytes do not rule out Addison’s disease. Approximately 30 to 40 percent of dogs with hypoadrenocorticism have atypical disease, in which only cortisol is deficient and electrolytes are completely normal. Atypical Addison’s produces all the glucocorticoid-deficiency signs (episodic weakness, vomiting, weight loss, poor appetite, hypoglycemia) without the classic hyponatremia and hyperkalemia. The only way to diagnose or rule out Addison’s disease is the ACTH stimulation test, not the electrolyte panel. Any dog with chronic episodic illness that fits the Addison’s clinical picture should have an ACTH stimulation test regardless of electrolyte results.
Addison’s disease is a death sentence for dogs.
With appropriate diagnosis and management, the vast majority of Addisonian dogs live completely normal lifespans with excellent quality of life. Long-term studies show that well-managed Addisonian dogs have survival times comparable to age-matched healthy dogs of the same breed. The disease requires lifelong daily or monthly medication, regular bloodwork monitoring, and owner education about stress dosing, but these are entirely manageable. The prognosis is far better than most owners fear at the time of diagnosis. The most important factors for a good outcome are: reaching diagnosis before irreversible crisis-related organ damage occurs, consistent medication administration, and owner understanding of stress dosing protocols.
Once my dog is stabilized on medication, I do not need to worry about emergencies anymore.
Even well-managed Addisonian dogs can experience acute crises if they face significant physiological stress without adequate glucocorticoid supplementation. The adrenal glands cannot produce a cortisol stress response regardless of how well the dog is managed at baseline; only the exogenous glucocorticoid supplement (prednisone, dexamethasone) can fill this role during stress. Owners must maintain a supply of prednisone at home, know the stress dosing protocol, and be prepared to seek emergency care if the dog vomits repeatedly despite oral supplementation (because absorbed dose is inadequate). Anesthesia and surgery always require stress dosing and typically intraoperative/perioperative glucocorticoid supplementation by the veterinary team.
Red Flags: Signs That Require Emergency Veterinary Care
- Collapse, profound weakness, and inability to stand with bradycardia (slow heart rate, below 60 beats per minute) in a dog showing signs of shock: this combination strongly suggests Addisonian crisis with hyperkalemia-induced cardiac conduction abnormality; call the emergency clinic immediately and describe the bradycardia on arrival
- Any previously diagnosed Addisonian dog who develops vomiting, diarrhea, or extreme lethargy and cannot keep oral prednisone down: oral stress dosing will be ineffective if vomiting; the dog needs injectable glucocorticoids (dexamethasone IV or IM) at the veterinary clinic or emergency hospital
- An undiagnosed dog with a history of repeated episodic vomiting and lethargy (3 or more episodes over months) that improves with IV fluids and supportive care then recurs: this waxing-and-waning pattern is highly characteristic of Addison’s disease; request electrolytes and ACTH stimulation testing at the next episode rather than repeating symptomatic treatment without a diagnosis
- Any dog with an unexplained reverse stress leukogram (lymphocytosis and eosinophilia on CBC) while systemically ill: this is a consistent Addison’s clue; request electrolyte measurement and ACTH stimulation testing
- Known Addisonian dog facing elective surgery: alert the surgical team to the Addison’s diagnosis well in advance; the team must plan perioperative glucocorticoid supplementation; failure to do so can result in intraoperative or perioperative crisis
Frequently Asked Questions About Addison’s Disease in Dogs
What is Addison’s disease in dogs?
Addison’s disease (hypoadrenocorticism) is a condition in which the adrenal glands fail to produce sufficient cortisol and/or aldosterone. In the most common form, the immune system attacks and destroys the adrenal cortex. Cortisol deficiency causes weakness, vomiting, hypoglycemia, and inability to respond to stress. Aldosterone deficiency causes sodium loss and potassium accumulation in the blood, producing the characteristic hyponatremia and hyperkalemia. It most commonly affects young to middle-aged female dogs of predisposed breeds (Standard Poodle, Bearded Collie, Portuguese Water Dog) but can occur in any breed.
What are the symptoms of Addison’s disease in dogs?
Symptoms are often episodic and vague: lethargy, weakness, reduced appetite, vomiting, diarrhea, weight loss, shaking, and increased thirst and urination. Many dogs are diagnosed only after an acute Addisonian crisis: collapse, profound weakness, bradycardia (slow heart rate), dehydration, and shock. The waxing-and-waning nature of the signs, which improve with IV fluids and relapse repeatedly, is highly characteristic. Atypical Addison’s (cortisol deficiency only, normal electrolytes) produces the same non-specific signs without the electrolyte abnormalities.
How is Addison’s disease diagnosed in dogs?
The gold standard is the ACTH stimulation test: baseline cortisol is drawn, synthetic ACTH (cosyntropin) is injected IV, and cortisol is remeasured 60 minutes later. In Addison’s disease, both baseline and post-stimulation cortisol are below 2 mcg/dL because the destroyed adrenal cortex cannot respond to ACTH. A baseline cortisol below 2 mcg/dL has approximately 98 percent sensitivity and is useful as a rapid screening test. Electrolytes showing a Na:K ratio below 27 suggest typical Addison’s but normal electrolytes do not rule out atypical Addison’s, which still requires the ACTH stimulation test for diagnosis.
How is Addison’s disease treated in dogs?
Long-term treatment requires lifelong hormone replacement. Mineralocorticoid replacement: monthly IM injections of DOCP (Percorten-V, 2.2 mg/kg every 25 to 28 days) or daily oral fludrocortisone (Florinef). Glucocorticoid replacement: low-dose daily prednisone (0.1 to 0.2 mg/kg/day) for dogs on DOCP. Stress dosing: the prednisone dose must be doubled or tripled during any stressful event (illness, surgery, travel, boarding). Acute crisis requires emergency IV 0.9% saline, dexamethasone, and careful ECG monitoring for hyperkalemia-induced arrhythmias.
Can dogs with Addison’s disease live a normal life?
Yes, with appropriate management, most Addisonian dogs live normal lifespans with excellent quality of life. The condition requires lifelong medication, regular bloodwork monitoring (every 3 to 6 months), and owner awareness of stress dosing. Dogs on stable management can exercise, travel, and do everything normal dogs do. The prognosis is far better than most owners fear at diagnosis. The most important outcomes predictors are: reaching diagnosis before irreversible crisis damage occurs, consistent medication administration, and thorough owner education about stress dosing.
What triggers an Addisonian crisis?
Any physiological stress can trigger crisis in a dog whose adrenal glands cannot mount a cortisol response. Common triggers include concurrent illness (infection, GI disease), surgery or anesthesia, significant trauma, travel stress, boarding, extreme weather changes, or vigorous exercise beyond the dog’s current tolerance. Sometimes no obvious trigger is identified, and the crisis appears to occur spontaneously as the adrenal reserve becomes exhausted. The solution is proactive stress dosing (doubling or tripling prednisone dose at the first sign of any stressor) rather than waiting for crisis to develop.
Is Addison’s disease in dogs hereditary?
The exact inheritance pattern is not fully established for most breeds, but familial clustering is clearly documented in Standard Poodles, Bearded Collies, and Portuguese Water Dogs, where multiple related individuals within families are affected. Immune-mediated diseases in general have a strong genetic component. Affected dogs of these breeds should not be used for breeding, and owners of related dogs (siblings, offspring of affected parents) should be aware of the elevated risk and monitor for early signs. Genetic testing panels for Addison’s susceptibility are in development for some breeds but are not yet clinically validated for routine screening.
For more guides on keeping your dog healthy, browse all our Dog Health articles.
Explore Dog Health Articles